Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer

Hinneh, JA; Gillis, JL; Mah, CY; Irani, S; Shrestha, RK; Ryan, NK; Atsushi, E; Nassar, ZD; Lynn, DJ; Selth, LA; Kato, M; Centenera, MM; Butler, LM

Butler, LM (通讯作者)，Univ Adelaide, South Australian Immunogen Canc Inst, Adelaide, SA 5000, Australia.;Butler, LM (通讯作者)，Univ Adelaide, Freemasons Ctr Male Hlth & Wellbeing, Adelaide, SA 5000, Australia.;Butler, LM (通讯作者)，South Australian Hlth & Med Res Inst, Precis Canc Med Theme, Adelaide, SA 5000, Australia.;Butler, LM (通讯作者)，Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.

BRITISH JOURNAL OF CANCER, 2023; 129 (8): 1350

Abstract

BackgroundResistance to androgen receptor signalling inhibitors (ARSIs) represents a major clinical challenge in prostate cancer. We previously demons......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索